window-to-japan.eu
  • Home
  • News
  • News of the month
  • Searches and Archives
  • Downloads
Select Page

Healios: retinal pigment epithelium (RPE) clinical trials from 2017

Jun 30, 2015

According to Healios’ CEO Hardy TS KAGIMOTO, Helios plans to start clinical trials with iPS-derived RPE in 2017 and hopes for approval in 2020. For international trials, cooperation with Lonza is envisioned. Nikkei Biotech news release, June 30, 2015

Rohto Pharmaceuticals installs Stem Cell Research Center in Okinawa, focus on adipose-derived adult stem cells.

Jun 27, 2015

The 800 m2 two story laboratory will be located in Nakagami, Okinawa, and focus on adipose stem cells, using serum-free media technology for expansion. R&D is done in collaboration with the University of the Ryukyus. Rohto press release, June 26, 2015

Toshiba tests H2One solar hydrogen generation system in Kawasaki City Harbor

Jun 23, 2015

The system with a photovoltaic power generation of 30 kW and 60 L/h of hot water supply has a hydrogen electric power storate capacity of 350 kWh. One of the applications of H2One is response to disasters: after a natural disaster, the system will be transported by...

ReproCell will start to sell „ReproNaive™“, a medium which keeps iPS cells in the undifferentiated state and triggers growth rate 100 fold

Jun 22, 2015

„ReproNaive™“ is a medium component which keeps iPS cells in the naive (unprimed) state for at least 10 days. It was developed by Naoki NISHISHITA at the Kobe Foundation for Biomedical Research and Innovation who is also Adviser to ReproCell. It will be sold from July...

Fuji Economy expects Euglena-related market to double by 2020, reaching 5 billion Yen (36 Mill. €)

Jun 19, 2015

The sales of Euglena-related products were 2,7 billion Yen in 2014, of which 80 % was in yoghurts, drinks and other health food, and the remainder in cosmetics. The products are mostly sold by the internet. Fuji Economy „2015 edition of useful biological components...
« Older Entries

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • February 2021
  • January 2021
  • September 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • October 2011
  • May 2011
  • April 2011
  • February 2011
  • January 2011
  • November 2010
  • October 2010
  • August 2010
  • About us…
  • Contact
  • Imprint
  • Privacy